Naphthoquine

DB16249InvestigationalSmall molecule

Naphthoquine is under investigation in clinical trial NCT01930331 (Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO).

Chemical structure of Naphthoquine
Formula / weight
C24H28ClN3O · 409.96 g/mol (avg)

Resolves to

Compound
UNIITRY8UD4E2HCAS173531-57-2
Clinical / RWD
RxNorm1721293ATCP01BF08
Structure
InChIKeyVEVMYTDOWUQLGI-UHFFFAOYSA-NSMILESCC(C)(C)NCC1=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=C2CCCCC2=C1O

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 7 drug categories
Sign in

Which companies are running trials of Naphthoquine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In